Burning Rock Biotech Ltd reports results for the quarter ended in June - Earnings Summary

Burning Rock Biotech

31/08/2022 14:31

* Burning Rock Biotech Ltd  BNR.OQ  reported a quarterly
adjusted
loss of CNY2.50​​ per share for the quarter ended in June. The
mean expectation of two analysts for the quarter was for a loss
of CNY2.40 per share.
    * Revenue rose 2.8% to CNY130.85 million from a year ago;
analysts
expected CNY151.60 million. 
    * Burning Rock Biotech Ltd's reported EPS for the quarter
was a
loss of CNY2.50​.
    * The mean earnings estimate of analysts was unchanged in
the last
three months.​ 
    * In the last 30 days there have been no earnings estimate
revisions by analysts covering the company. 
    * Burning Rock Biotech Ltd shares had risen by 11.7% this
quarter and lost 65.9% so far this year.
    * The company reported a quarterly loss of CNY262.14
million.
    * Wall Street's median 12-month price target for Burning
Rock
Biotech Ltd is $12.80 
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 4 "strong buy" or "buy," no
"hold" and no "sell" or "strong sell." 

This summary was machine generated from Refinitiv data August 31
at 01:31 p.m.  ​All figures in Chinese yuan renminbi unless
otherwise stated. QUARTER ENDING    ESTIMATE       ACTUAL         BEAT, MET,
                                                 MISSED
 Jun. 30 2022      -2.40          -2.50          Missed
 Mar. 31 2022      -2.41          -2.50          Missed
 Dec. 31 2021      -1.69          -2.40          Missed
 Sep. 30 2021      -1.61          -1.64          Missed